(S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide

We are (S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide CAS:42267-27-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide
CAS.NO:42267-27-6
Synonyms:(S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide
N-(4-(2,5-Dioxo-4-oxazolidinyl)butyl)-2,2,2-trifluoroacetamide
N-[4-[(4S)-2,5-dioxo-1,3-oxazolidin-4-yl]butyl]-2,2,2-trifluoroacetamide
N-Trifluoroacetyl L-Lysine N-Carboxy anhydride
N6-Trifluoroacetyl-L-lysine N-carboxy anhydride
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Melting Point 92-93ºC (DEC.)
Molecular Formula C9H11F3N2O4
Molecular Weight 268.190
Index of Refraction 1.437
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥95.0%
Melting Point:92-93ºC
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Glatiramer acetate(CAS:147245-92-9).

(S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide


Related News: The iLet Bionic Pancreas System is a pocket-sized, wearable investigational medical device that is designed to autonomously control blood-sugar levels.163521-20-8 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.Pentachloropyridine CAS:2176-62-7 Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.1-Bromo-4-iodobenzene In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates.

Related Products
Product Name
2,4,6-Trifluorobenzonitrile View Details
1-Bromo-3-chloropropane View Details
L-Histidine View Details
3-Fluoro-4-nitrophenol manufacturer 3-Fluoro-2-methylpyridine manufacturer (S)-2-Benzothiazolyl (Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminothioacetate manufacturer Isovaleryl chloride manufacturer 2-Bromophenol manufacturer